The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015–2025)
Theranostics · 01.05.2026 · 16 (12) · 6576-6599
DOI: 10.7150/thno.130266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 01.05.2026. Verfasst von Biao Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Receptors, CXCR4, Theranostic Nanomedicine, Molecular Targeted Therapy, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China.
- Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan 430022, China.
Zitieren
APA
Yang, B., Hu, W., Zhang, X., Gai, Y., An, R., Qin, C., Li, M., & Lan, X. (2026). The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015–2025). Theranostics, 16(12), 6576-6599. https://doi.org/10.7150/thno.130266
Vancouver
Yang B, Hu W, Zhang X, Gai Y, An R, Qin C, et al. The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015–2025). Theranostics. 2026;16(12):6576-6599. doi:10.7150/thno.130266
BibTeX
@article{Yang2026,
author = {Yang, Biao and Hu, Wenzhu and Zhang, Xiao and Gai, Yongkang and An, Rui and Qin, Chunxia and Li, Mengting and Lan, Xiaoli},
title = {The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015–2025)},
journal = {Theranostics},
year = {2026},
volume = {16},
number = {12},
pages = {6576--6599},
doi = {10.7150/thno.130266}
}
EUVIMED